HomeInsightsMarket Capitalization

Market Capitalization of Jagsonpal Pharmaceuticals Ltd

Market Capitalization of Jagsonpal Pharmaceuticals Ltd

stocks purchased

₹ 0.6 Cr

Volume transacted

stocks purchased

10.3 K

stocks traded

Last Updated time: 04 Nov 15:30 PM

Image

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM

MARKETCAP

1453.74 crore

Last updated on: Nov 01, 2024

Key Highlights

  • The Market Cap of Jagsonpal Pharmaceuticals Ltd is ₹ 1453 crore as of 01 Nov 24.
  • The Market Cap of Jagsonpal Pharmaceuticals Ltd changed from ₹ 68.9 crore on March 2019 to ₹ 737.06 crore on March 2024 . This represents a CAGR of 48.44% over 6 years. .
  • The Latest Trading Price of Jagsonpal Pharmaceuticals Ltd is ₹ 537.55 as of 04 Nov 15:30.

Historical Market Cap of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Jagsonpal Pharmaceuticals Ltd

No data available

Image

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM

PRICE

537.55

-11.35 (-2.07%)

stock direction

Last updated on: Nov 04 03:30 PM

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Jagsonpal Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
01 Nov 2024548.9
31 Oct 2024543.3
30 Oct 2024521.95
29 Oct 2024467.65
28 Oct 2024469.5
25 Oct 2024449.45
24 Oct 2024478.9
23 Oct 2024471.35
22 Oct 2024459.4
21 Oct 2024486.45

SWOT Analysis Of Jagsonpal Pharmaceuticals Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Jagsonpal Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Jagsonpal Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Jagsonpal Pharmaceuticals Ltd

No data available

Historical P/E Ratio of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in %

About Jagsonpal Pharmaceuticals Ltd

  • Promoted by J S Kochhar in 1978, Jagsonpal Pharmaceuticals is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
  • The company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
  • Simultaneously it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
  • It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
  • In 1994, the company has also promoted Aresco Financial Services, a new financial company.

Jagsonpal Pharmaceuticals Ltd News Hub

News

Jagsonpal Pharmaceuticals to table results

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

17 Oct 202412:13

News

Jagsonpal Pharmaceuticals AGM scheduled

Jagsonpal Pharmaceuticals announced that the 45th Annual General Meeting (AGM) of the comp...

Read more

13 Aug 202414:22

News

Jagsonpal Pharmaceuticals declare Quarterly Result

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

01 Aug 202411:06

News

Jagsonpal Pharmaceuticals completes acquisition of India and Bhutan biz of Yash Pharma

Jagsonpal Pharmaceuticals completed the acquisition of India & Bhutan business of Yash Pha...

Read more

31 May 202414:15

News

Board of Jagsonpal Pharmaceuticals recommends final dividend

Jagsonpal Pharmaceuticals announced that the Board of Directors of the Company at its meet...

Read more

21 May 202409:56

News

Jagsonpal Pharmaceuticals Ltd leads losers in 'B' group

Pakka Ltd, IFGL Refractories Ltd, Mangalore Chemicals & Fertilizers Ltd and SBC Exports Lt...

Read more

05 Feb 202414:45

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Jagsonpal Pharmaceuticals Ltd Market Cap

What is the market cap of Jagsonpal Pharmaceuticals Ltd?

As of November 4, 2024, Jagsonpal Pharmaceuticals Ltd has a market capitalization of ₹1453.74, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Jagsonpal Pharmaceuticals Ltd's market capitalization?

Jagsonpal Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Jagsonpal Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Jagsonpal Pharmaceuticals Ltd's market capitalization change?

Jagsonpal Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*